Spruce Biosciences, Inc. (SPRB) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $2.50M; Long-term Debt, Excluding Current MaturitiesUSD $4.59M; Long-term DebtUSD $19.94M; Long-Term Debt, Maturity, Year OneUSD $939.00K.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $1.00M; Long-term Debt, Excluding Current MaturitiesUSD $5.46M; Long-term DebtUSD $20.41M; Long-Term Debt, Maturity, Year OneUSD $1.40M.
- 2026-01-07: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
Spruce Biosciences, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Commitment Fee Amount USD | Long-term Debt, Gross USD | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Long-Term Debt, Maturity, Year Five USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.50M | $4.59M | $19.94M | $939.00K | $7.02M | $6.78M | $5.21M | (m) | (m) | $16.60M | (m) | (m) | $9.51M | (m) |
| 2026-03-31 | $1.00M | $5.46M | $20.41M | $1.40M | $7.02M | $6.78M | $5.21M | (m) | (m) | $16.60M | (m) | (m) | $10.14M | (m) |
| 2026-01-07 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00K | (m) | (m) | 60.00 | (m) | (m) |
| 2025-12-31 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $539.00K | $0.00 | $549.00K | $413.00K | $136.00K | (m) | (m) | (m) | (m) | (m) | $800.00K | (m) | $1.00K | (m) |
| 2025-06-30 | $943.00K | $0.00 | $972.00K | $836.00K | $136.00K | (m) | (m) | (m) | (m) | (m) | $1.20M | (m) | $3.00K | (m) |
| 2025-03-31 | $1.34M | $0.00 | $1.40M | $1.27M | $136.00K | (m) | (m) | (m) | (m) | (m) | $1.60M | (m) | $7.00K | (m) |
| 2024-12-31 | $1.62M | $124.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.00M | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $1.84M | $1.70M | $136.00K | (m) | (m) | (m) | (m) | $1.76M | (m) | (m) | $11.00K | (m) |
| 2024-09-30 | $1.62M | $524.00K | $2.29M | $1.71M | $136.00K | (m) | (m) | $450.00K | (m) | $2.16M | $2.40M | (m) | $17.00K | (m) |
| 2024-06-30 | $1.62M | $923.00K | $2.76M | $913.00K | $1.71M | $136.00K | (m) | (m) | (m) | $2.57M | $2.80M | (m) | $23.00K | (m) |
| 2024-03-31 | $1.62M | $1.32M | $3.23M | $1.38M | $1.71M | $136.00K | (m) | (m) | (m) | $2.97M | $3.20M | (m) | $31.00K | (m) |
| 2023-12-31 | $1.62M | $1.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.60M | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $3.71M | $1.86M | $1.71M | $136.00K | (m) | (m) | (m) | $3.38M | (m) | (m) | $39.00K | (m) |
| 2023-09-30 | $1.62M | $2.11M | $4.20M | $488.00K | $1.86M | $1.71M | $136.00K | (m) | (m) | $3.78M | $4.00M | (m) | $49.00K | (m) |
| 2023-06-30 | $1.62M | $2.51M | $4.68M | $982.00K | $1.86M | $1.71M | $136.00K | (m) | (m) | $4.19M | $4.20M | (m) | $60.00K | (m) |
| 2023-03-31 | $1.62M | $2.90M | $5.17M | $1.48M | $1.85M | $1.71M | $136.00K | (m) | (m) | $4.59M | $4.50M | (m) | $72.00K | (m) |
| 2022-12-31 | $1.62M | $3.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.90M | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $5.64M | $1.97M | $1.84M | $1.70M | $136.00K | (m) | (m) | $5.00M | (m) | (m) | $85.00K | (m) |
| 2022-09-30 | $1.22M | $3.69M | $5.62M | $82.00K | $1.91M | $1.80M | $1.69M | (m) | (m) | $5.00M | $4.90M | (m) | $99.00K | $135.00K |
| 2022-06-30 | $811.00K | $4.08M | $4.89M | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | $4.70M | (m) | $112.00K | (m) |
| 2022-03-31 | $405.00K | $4.49M | $4.89M | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | $5.00M | (m) | $110.00K | (m) |
| 2021-12-31 | $0.00 | $4.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $4.88M | (m) | $1.62M | $1.62M | $1.62M | (m) | (m) | $5.00M | (m) | (m) | $122.00K | $135.00K |
| 2021-09-30 | $0.00 | $4.87M | $4.87M | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | $5.00M | (m) | $133.00K | (m) |
| 2021-06-30 | $0.00 | $4.86M | $4.86M | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | $5.00M | (m) | $145.00K | (m) |
| 2021-03-31 | $0.00 | $4.84M | $4.84M | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | $5.00M | (m) | $157.00K | (m) |
| 2020-12-31 | $2.55M | $1.92M | $4.48M | (m) | (m) | (m) | (m) | (m) | (m) | $4.50M | (m) | (m) | $24.00K | (m) |
| 2020-12-31 | (m) | (m) | (m) | $2.57M | $1.93M | (m) | (m) | (m) | (m) | (m) | $4.80M | (m) | (m) | (m) |
| 2020-09-30 | $1.91M | $2.56M | $4.47M | $2.57M | $1.93M | (m) | (m) | $0.00 | (m) | $4.50M | $4.80M | (m) | $31.00K | (m) |
| 2019-12-31 | $1.25M | $3.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |